title: Increased phospholipase activity in Helicobacter pylori strains isolated from patients with gastric carcinoma.
abstract: OBJECTIVE
  Phospholipase activity, one of Helicobacter pylori pathogenicity factors, has not been investigated enough, so far, although it may induce a remarkable damage to the gastric mucosa. In the present work, we have compared the whole phospholipase activity of H. pylori strains isolated from patients with gastric carcinoma with that of strains isolated from dyspeptic patients without gastric carcinoma.
  
  
  METHODS
  We measured the phospholipase activity of one distinct H. pylori colony isolated from each of 10 patients with gastric carcinoma and 10 controls, dyspeptic patients without endoscopic and histological signs of gastric carcinoma. We also determined the phospholipase activity of 20 additional strains isolated from different areas of neoplastic and non-neoplastic tissue of two patients with gastric carcinoma, the cagA and vacA positive G27 and 328 wild strains and their respective vacA and cagA negative isogenic mutants. The whole phospholipase activity of strains was determined by measuring the release of (14)C-labeled palmitic acid from the radioactive l-3-phosphatidylcholine, 1,2-di[1-(14)C]palmiloyl substrate; results were expressed in pmol of palmitic acid per mg of protein.
  
  
  RESULTS
  H. pylori strains isolated from patients with gastric carcinoma had levels of phospholipase activity significantly higher than those of strains isolated from controls (99.37 [S.D. 40.45] versus 34.46 [S.D. 16.46], P<0.001). In patients with gastric carcinoma, the mean phospholipase activity of strains isolated from neoplastic tissue was similar to that of strains isolated from non-neoplastic tissues (123.02 [S.D. 44.36] and 115.77 [S.D. 81.48], respectively. Interruption of cagA gene caused a ca. 20% reduction of phospholipase activity (36.38 versus 45.22 of the wild strain); that of vacA caused no reduction of phospholipase activity (26.53 and 25.37 of the wild strain).
  
  
  CONCLUSIONS
  The infection by H. pylori strains that produce high levels of phospholipase may increase the risk of developing gastric carcinoma. We hypothesise that indirect products of phospholipase activity, such as prostaglandins, leukotrienes and lysophospholipids, may mediate carcinogenesis.
authors.affiliation: Department of Molecular Biology, University of Siena, 53100 Siena, Italy.
authors.forename: P
authors.initials: P
authors.lastname: Lusini
authors.forename: N
authors.initials: N
authors.lastname: Figura
authors.forename: M
authors.initials: M
authors.lastname: Valassina
authors.forename: F
authors.initials: F
authors.lastname: Roviello
authors.forename: C
authors.initials: C
authors.lastname: Vindigni
authors.forename: L
authors.initials: L
authors.lastname: Trabalzini
authors.forename: R
authors.initials: R
authors.lastname: Nuti
authors.forename: C
authors.initials: C
authors.lastname: Lenzi
authors.forename: C
authors.initials: C
authors.lastname: Gonnelli
authors.forename: M
authors.initials: M
authors.lastname: Nardi
authors.forename: P
authors.initials: P
authors.lastname: Martelli
authors.forename: A
authors.initials: A
authors.lastname: Santucci
mesh_terms: D000942:Antigens, Bacterial / Q000235:genetics; D001426:Bacterial Proteins / Q000235:genetics; D001706:Biopsy; D002908:Chronic Disease; D004415:Dyspepsia / Q000382:microbiology / Q000473:pathology; D020776:Endoscopes, Gastrointestinal; D005756:Gastritis / Q000382:microbiology / Q000473:pathology; D041981:Gastrointestinal Tract / Q000382:microbiology / Q000473:pathology; D016481:Helicobacter Infections / Q000382:microbiology* / Q000473:pathology; D016480:Helicobacter pylori / Q000201:enzymology* / Q000235:genetics / Q000302:isolation & purification; D006801:Humans; D009154:Mutation; D019308:Palmitic Acid / Q000378:metabolism; D010713:Phosphatidylcholines / Q000378:metabolism; D010740:Phospholipases / Q000032:analysis*; D013045:Species Specificity; D013274:Stomach Neoplasms / Q000382:microbiology* / Q000473:pathology
chemical_list: D000942:Antigens, Bacterial; D001426:Bacterial Proteins; D010713:Phosphatidylcholines; C074689:VacA protein, Helicobacter pylori; C080866:cagA protein, Helicobacter pylori; D019308:Palmitic Acid; D010740:Phospholipases